Application of tetrandrine in hepatic stellate cell migration inhibition drug preparation

A technology of hepatic stellate cells and tetrandrine, which is applied in the application field of medicine and can solve problems such as no relevant reports.
CN102988367AInactive Publication Date: 2013-03-27SHUGUANG HOSPITAL AFFILIATED WITH SHANGHAI UNIV OF T C M

Patent Information

Authority / Receiving Office
CN Β· China
Patent Type
Applications(China)
Current Assignee / Owner
SHUGUANG HOSPITAL AFFILIATED WITH SHANGHAI UNIV OF T C M
Publication Date
2013-03-27
Estimated Expiration
Not applicable Β· inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The present invention discloses an application of tetrandrine in hepatic stellate cell migration inhibition drug preparation. According to the present invention, a PDGF-induced human hepatic stellate cell line (LX-2) migration screening platform is designed, and results show that PDGF-induced hepatic stellate cell (HSC) migration can be inhibited with 10<-4>-10<-7> mol / L tetrandrine.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of traditional Chinese medicines, and in particular relates to the application of tetrandrine in the preparation of medicines for inhibiting the migration of hepatic stellate cells. Background technique

[0002] Tetrandrine, also known as tetrandrine, is the main biologically active component of Tetradontidae plant, belonging to the bisbenzyl isoquinoline compound, is Ca 2+ Antagonist, which can both block membrane voltage-gated channel-mediated Ca 2+ Influx, can also block receptor-gated channels interfering with intracellular Ca 2+ distribution, thereby blocking relevant pathological processes; such as inhibiting the proliferation of fibroblasts, the synthesis and excretion of ECM (extracellular matrix, extracellular matrix), and the promotion of fibrosis by growth factors. Studies have found that it has a good therapeutic effect on the cardiovascular system, liver, pulmonary fibrosis, and inflammatory response. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More